{
  "metadata": {
    "case_id": 74,
    "model": "Gemini-3-Pro",
    "timestamp": "2025-11-29T18:31:27.636632",
    "total_alignments": 4,
    "target_section": "protocolSection",
    "ground_truth_path": "/{YOURPATH}/samples/CTG/protocolSection/1_100/74_NCT03959423.json",
    "prediction_path": "/{YOURPATH}/restructured_outputs_protocol/Gemini-3-Pro/74_Gemini-3-Pro.json",
    "shard_range": "1_100"
  },
  "alignments": [
    {
      "field_path": "protocolSection.armsInterventionsModule.armGroups",
      "algorithm": "hungarian",
      "ref_count": 1,
      "pred_count": 1,
      "similarity_matrix": [
        [
          0.78
        ]
      ],
      "matched_pairs": [
        {
          "ref_idx": 0,
          "pred_idx": 0,
          "score": 0.78,
          "status": "matched",
          "ref_item": {
            "label": "Subjects 7-75 years of age",
            "type": "EXPERIMENTAL",
            "description": "Subjects who have been diagnosed with type 1 diabetes",
            "interventionNames": [
              "Device: AHCL insulin pump system"
            ]
          },
          "pred_item": {
            "label": "MiniMed AHCL System Group",
            "type": "EXPERIMENTAL",
            "description": "Participants with Type 1 Diabetes (adolescents and adults) participating in a single-arm study. They utilized the MiniMed AHCL system through a baseline run-in period followed by a study phase with automated features enabled.",
            "interventionNames": [
              "Device: MiniMed AHCL System"
            ]
          }
        }
      ]
    },
    {
      "field_path": "protocolSection.armsInterventionsModule.interventions",
      "algorithm": "hungarian",
      "ref_count": 1,
      "pred_count": 1,
      "similarity_matrix": [
        [
          0.86
        ]
      ],
      "matched_pairs": [
        {
          "ref_idx": 0,
          "pred_idx": 0,
          "score": 0.86,
          "status": "matched",
          "ref_item": {
            "type": "DEVICE",
            "name": "AHCL insulin pump system",
            "description": "670G 4.0 system with GS3; 780G system with G4S (continued access phase);",
            "armGroupLabels": [
              "Subjects 7-75 years of age"
            ]
          },
          "pred_item": {
            "type": "DEVICE",
            "name": "MiniMed AHCL System",
            "description": "The system consisted of the MiniMed 670G insulin pump (version 4.0 algorithm) with the Guardian Sensor 3 glucose sensor and Guardian Link 3 transmitter. During the run-in period (~14 days), participants used the system as a sensor-augmented pump with or without predictive low glucose management or Auto Basal. During the study phase (~90 days), Auto Basal and automated bolus correction (Auto Correction) were enabled, with glucose targets set to 100 or 120 mg/dL for alternating periods.",
            "armGroupLabels": [
              "MiniMed AHCL System Group"
            ]
          }
        }
      ]
    },
    {
      "field_path": "protocolSection.outcomesModule.primaryOutcomes",
      "algorithm": "hungarian",
      "ref_count": 2,
      "pred_count": 3,
      "similarity_matrix": [
        [
          0.4,
          0.96,
          0.15
        ],
        [
          0.92,
          0.4,
          0.1
        ]
      ],
      "matched_pairs": [
        {
          "ref_idx": 0,
          "pred_idx": 1,
          "score": 0.96,
          "status": "matched",
          "ref_item": {
            "measure": "Change in HbA1c",
            "description": "The overall mean difference of the change in HbA1c from baseline to end of 3-month Study Period.",
            "timeFrame": "Baseline to End of 3-Month Study Period"
          },
          "pred_item": {
            "measure": "Change in mean Hemoglobin A1C",
            "description": "Overall change in the mean A1C",
            "timeFrame": "From end of run-in period (approx. 14 days) to end of study phase (approx. 90 days)"
          }
        },
        {
          "ref_idx": 1,
          "pred_idx": 0,
          "score": 0.92,
          "status": "matched",
          "ref_item": {
            "measure": "Change in Percentage of Euglycemia",
            "description": "The overall mean change in % of time in euglycemia (70-180 mg/dL) from baseline to end of 3-month Study Period will be estimated.",
            "timeFrame": "Baseline to End of 3-Month Study Period"
          },
          "pred_item": {
            "measure": "Change in mean Time in Range (TIR)",
            "description": "Overall change in the mean TIR (sensor glucose 70â€“180 mg/dL)",
            "timeFrame": "From end of run-in period (approx. 14 days) to end of study phase (approx. 90 days)"
          }
        }
      ]
    },
    {
      "field_path": "protocolSection.outcomesModule.secondaryOutcomes",
      "algorithm": "hungarian",
      "ref_count": 3,
      "pred_count": 5,
      "similarity_matrix": [
        [
          0.18,
          0.2,
          0.63,
          0.18,
          0.18
        ],
        [
          0.08,
          0.12,
          0.2,
          0.2,
          0.08
        ],
        [
          0.4,
          0.3,
          0.9,
          0.4,
          0.35
        ]
      ],
      "matched_pairs": [
        {
          "ref_idx": 0,
          "pred_idx": 1,
          "score": 0.2,
          "status": "matched",
          "ref_item": {
            "measure": "Number of Severe Hypoglycemic Event",
            "description": "Number of severe hypoglycemic events occurred during 3-month Study Period",
            "timeFrame": "3-month Study Period"
          },
          "pred_item": {
            "measure": "Change in Coefficient of Variation (CV) of SG",
            "description": "Change in glucose variability measured by CV of SG",
            "timeFrame": "From end of run-in period to end of study phase"
          }
        },
        {
          "ref_idx": 1,
          "pred_idx": 3,
          "score": 0.2,
          "status": "matched",
          "ref_item": {
            "measure": "Number of Diabetic Ketoacidosis (DKA) Event",
            "description": "Number of Diabetic Ketoacidosis (DKA) event occurred during 3-month Study Period",
            "timeFrame": "3-month Study Period"
          },
          "pred_item": {
            "measure": "Time spent in hyperglycemic ranges",
            "description": "Percentage of time spent at hyperglycemic ranges (>180, 250, and 300 mg/dL)",
            "timeFrame": "From end of run-in period to end of study phase"
          }
        },
        {
          "ref_idx": 2,
          "pred_idx": 2,
          "score": 0.9,
          "status": "matched",
          "ref_item": {
            "measure": "Change in Percent of Time in Hypoglycemic Range (<70 mg/dL)",
            "description": "The overall mean change in % of time in hypoglycemic range (\\<70 mg/dL) from baseline to end of 3-month Study Period will be estimated.",
            "timeFrame": "Baseline to End of 3-Month Study Period"
          },
          "pred_item": {
            "measure": "Time spent in hypoglycemic ranges",
            "description": "Percentage of time spent at hypoglycemic ranges (<50, 54, and 70 mg/dL)",
            "timeFrame": "From end of run-in period to end of study phase"
          }
        }
      ]
    }
  ]
}